newsfilter
← Latest News
PR Newswire·

Dynavax Announces $200 Million Share Repurchase Program

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines,...